Skip to main content
Equibles

MORGAN STANLEY

Position in VERU — Veru Inc.

CIK 895421 NEW YORK, NY
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,852
+$11,467 QoQ
Shares Held
6,662
+56.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. VERU ranks #398 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in VERU

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,852 6,662
2026-03-31 $9,385 4,247
2025-12-31 $9,137 4,270
2025-09-30 $68,376 17,994
2025-06-30 $142,770 246,161
2025-03-31 $184,415 376,367
2024-12-31 $951,662 1,464,099
2024-09-30 $2,321,264 3,014,633
2024-06-30 $2,346,640 2,793,624
2024-03-31 $1,912,254 2,731,799
2023-12-31 $1,965,683 2,730,119
2023-09-30 $2,742,794 3,809,440
2023-06-30 $6,154,974 5,172,250
2023-03-31 $8,278,351 7,136,512
2022-12-31 $38,511,217 7,293,792
2022-09-30 $73,086,493 6,344,314
2022-06-30 $11,347,196 1,004,177
2022-03-31 $897,971 185,916
2021-12-31 $1,840,462 312,473
2021-09-30 $2,948,262 345,635
2021-06-30 $3,230,250 400,279
2021-03-31 $11,180,767 1,037,177
2020-12-31 $2,039,435 235,773
2020-09-30 $63,492 24,234
2020-06-30 $1,202,188 359,937
2020-03-31 $1,058,070 323,569